These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 34454298)
1. Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors. Wang S; Wang X; Shao Y; Shao K; Wang Y; Guo X; Dong H; Zhao W; Li Y; Li G Bioorg Chem; 2021 Nov; 116():105298. PubMed ID: 34454298 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of antitumor activity in Pseudolaric acid B Azole derivatives: Novel and potent angiogenesis inhibitor via regulation of the PI3K/AKT and MAPK mediated HIF-1/VEGF signaling pathway. Deng H; Xu Q; Li XT; Huang X; Liu JY; Yan R; Quan ZS; Shen QK; Guo HY Eur J Med Chem; 2024 Nov; 278():116813. PubMed ID: 39226705 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway. Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802 [TBL] [Abstract][Full Text] [Related]
4. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties. Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229 [TBL] [Abstract][Full Text] [Related]
5. Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathways. Wang JY; Wang Z; Li MY; Zhang Z; Mi C; Zuo HX; Xing Y; Wu YL; Lian LH; Xu GH; Piao LX; Ma J; Jin X Chem Biol Interact; 2018 Dec; 296():134-144. PubMed ID: 30266538 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and target identification of new hypoxia-inducible factor 1 (HIF-1) inhibitors containing 1-alkyl-1H-pyrazole-3-carboxamide moiety. Sakai M; Takahashi N; Ikeda H; Furutani Y; Higuchi S; Suzuki T; Dohmae N; Kobayashi S; Harada H; Kojima S; Matsuura T; Hattori A; Kakeya H Bioorg Med Chem; 2021 Sep; 46():116375. PubMed ID: 34492592 [TBL] [Abstract][Full Text] [Related]
7. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues. Xia Y; Jin Y; Kaur N; Choi Y; Lee K Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991 [TBL] [Abstract][Full Text] [Related]
8. Discovery of Antimetastatic Chiral Ionone Alkaloid Derivatives Targeting HIF-1α/VEGF/VEGFR2 Pathway. Liu JJ; Liu XY; Nie JP; Jia MQ; Yu Y; Qin N; Duan HQ ChemMedChem; 2021 Jul; 16(13):2130-2145. PubMed ID: 33755334 [TBL] [Abstract][Full Text] [Related]
9. Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment. Narise K; Okuda K; Enomoto Y; Hirayama T; Nagasawa H Drug Des Devel Ther; 2014; 8():701-17. PubMed ID: 24944508 [TBL] [Abstract][Full Text] [Related]
10. Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors. Kim HS; Hong M; Lee SC; Lee HY; Suh YG; Oh DC; Seo JH; Choi H; Kim JY; Kim KW; Kim JH; Kim J; Kim YM; Park SJ; Park HJ; Lee J Eur J Med Chem; 2015 Nov; 104():157-64. PubMed ID: 26457742 [TBL] [Abstract][Full Text] [Related]
11. 2,2- dimethylbenzopyran derivatives containing pyridone structural fragments as selective dual-targeting inhibitors of HIF-1α and EZH2 for the treatment of lung cancer. Xu H; Zhang J; Zhuang J; Chen Y; Chen L; Wang J; Cao R; Liu F; Wang K; Zhang X; Wang L; Chen G Bioorg Chem; 2024 Jun; 147():107419. PubMed ID: 38703440 [TBL] [Abstract][Full Text] [Related]
12. Semi-Synthesis and In Vitro Anti-Cancer Evaluation of Magnolol Derivatives. Sun XL; Zhu ML; Dai YQ; Li HM; Li BH; Ma H; Zhang CH; Wu CZ Molecules; 2021 Jul; 26(14):. PubMed ID: 34299577 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships study of neolamellarin A and its analogues as hypoxia inducible factor-1 (HIF-1) inhibitors. Li G; Dong H; Ma Y; Shao K; Li Y; Wu X; Wang S; Shao Y; Zhao W Bioorg Med Chem Lett; 2019 Aug; 29(16):2327-2331. PubMed ID: 31281016 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel natural product-like diaryl acetylenes as hypoxia inducible factor-1 inhibitors and antiproliferative agents. Wang S; Liu L; Guo X; Li G; Wang X; Dong H; Li Y; Zhao W RSC Adv; 2019 Apr; 9(24):13878-13886. PubMed ID: 35519548 [TBL] [Abstract][Full Text] [Related]
15. Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis. Liu M; Liang Y; Zhu Z; Wang J; Cheng X; Cheng J; Xu B; Li R; Liu X; Wang Y J Med Chem; 2019 Oct; 62(20):9299-9314. PubMed ID: 31556611 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway. Xu XL; Yang YR; Mo XF; Wei JL; Zhang XJ; You QD Eur J Med Chem; 2017 Sep; 137():45-62. PubMed ID: 28554092 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 14 and 15-membered macrocyclic scaffolds exhibiting inhibitory activities of hypoxia-inducible factor 1α. Shimizu T; Takahashi N; Huber VJ; Asawa Y; Ueda H; Yoshimori A; Muramatsu Y; Seimiya H; Kouji H; Nakamura H; Oguri H Bioorg Med Chem; 2021 Jan; 30():115949. PubMed ID: 33360196 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of HIF-1α inhibitory activities of novel panaxadiol derivatives. Wang DY; Li YW; Zhang LH; Lv LY; Zhao YQ; Jin XJ; Piao HR Bioorg Med Chem Lett; 2020 Dec; 30(24):127652. PubMed ID: 33130293 [TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship of N-(piperidin-4-yl)benzamide derivatives as activators of hypoxia-inducible factor 1 pathways. Huang ZN; Liang H; Qiao H; Wang BR; Qu N; Li H; Zhou RR; Wang LJ; Li SH; Li FN Arch Pharm Res; 2018 Dec; 41(12):1149-1161. PubMed ID: 29998374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]